MedPath

Chemillennium International (H.K.) Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

68

PPB:68

Drug Approvals

ABIRATERONE ACETATE TABLETS USP 250MG

Approval Date
Dec 23, 2024
PPB

NATZO 8 TABLETS 8MG

Approval Date
Apr 27, 2020
PPB

NATZO 4 TABLETS 4MG

Approval Date
Apr 27, 2020
PPB

EFAVIRENZ TABLETS 200MG

Approval Date
Apr 16, 2020
PPB

FULVESTRANT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 250MG/5ML

Approval Date
Jan 30, 2020
PPB

OXYBUTYNIN CHLORIDE TABLETS USP 5MG

Approval Date
Sep 27, 2019
PPB

ATOSIBAN CONCENTRATE FOR SOLUTION FOR INFUSION 37.5MG/5ML

Approval Date
Aug 28, 2019
PPB

ATOSIBAN SOLUTION FOR INJECTION 6.75MG/0.9ML

Approval Date
Aug 28, 2019
PPB

OFLO OPHTHALMIC SOLUTION 0.3% W/V

Approval Date
Mar 29, 2019
PPB

VEXOR EXTENDED RELEASE CAPSULES 150MG

Approval Date
Jun 11, 2018
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.